Support for Caregivers Takes Many Forms When the patient with a complex chronic condition is also your spouse, parent or child, you walk every step of the journey with them. Family members are part of the care team. In fact, over 40 million adults in the United States are providing unpaid care to a loved one in their homes and

Yes, Medicare can Embrace Innovation A recent announcement by Medicare may brighten the day of some cancer patients. Medicare just released a National Coverage Decision on the breakthrough immunotherapy cancer treatment known as CAR T. CAR T-cell therapy treatment involves removing and genetically engineering a patient’s immune system T-cells, multiplying the modified cells, and then returning them to the body

Cancer patients are being denied drugs, even with doctor prescriptions and good insurance BY CARMEN GEORGE AUGUST 02, 2019 06:40 AM As seen on fresnobee.com. Norma Smith was diagnosed with stage-three cancer in December. There are four stages to cancer and number three means the cancer - in Smith's case, a blood cancer, multiple myeloma - had spread extensively. As

Middlemen Disrupt Patient Access to Personalized Care Allowing a middleman with no medical training and no clinical experience to interfere with a treatment plan disrupts patient access to personalized treatment. The International Pricing Index (IPI) proposal would force an untested, new payment model for Medicare Part B therapies - drugs administered to patients in physician offices and infusion clinics-on America's

Don't Put Barriers between Patients and Care Medicare is proposing to insert a middleman in the Part B drug supply chain. This would erect a barrier between patients and the personalized therapies that their physician prescribes to treat a serious chronic condition such as cancer, rheumatoid arthritis, macular degeneration, Crohn's disease, or immunodeficiency diseases. These barriers take the form of

Cancer Care Close to Home Benefits Patients in Many Ways A recent study by researchers from the University of Alabama Birmingham found measurable differences for patients when cancer treatment is delivered close to home. Gabrielle B. Rocque, MD, and her colleagues found that travel time is a drag on cancer care. Medpage Today reported on the study of 23,000 Medicare